[144] CNA Financial Corporation SEC Filing

Rhea-AI Filing Summary

CNA Financial Corporation (CNA) Form 144 summary: A holder acquired 10,000 common shares as performance awards on 03/15/2025 and proposes to sell the same 10,000 shares on or about 09/03/2025 through Goldman Sachs & Co. LLC. The filing reports an aggregate market value of $489,200 for the shares and states 270,665,399 shares outstanding for the issuer. The acquisition and payment are recorded as compensation. The filer reports nothing to report for securities sold in the past three months and includes the standard representation that no undisclosed material adverse information is known.

Positive

• Clear disclosure of acquisition date, nature (performance awards), broker, proposed sale date, and aggregate market value
• No securities sold in the prior three months reported, simplifying aggregation rules under Rule 144
• Filer representation that no undisclosed material adverse information is known, aligning with compliance expectations

Negative

• None.

Insights

Financial Analyst

TL;DR: Insider plans to sell recently granted performance shares worth $489,200; disclosure demonstrates routine compliance.

The filing shows a proposed sale of 10,000 common shares acquired as performance compensation on 03/15/2025 and to be sold via Goldman Sachs on 09/03/2025. The reported aggregate value is $489,200 against 270,665,399 shares outstanding, indicating the position size is immaterial to overall capitalization based on disclosed figures. No prior sales in the past three months are reported, and the signee affirms no undisclosed material adverse information. This is a routine Rule 144 notice documenting an intended sale of restricted/controlled securities following compensation vesting.

Corporate Governance Expert

TL;DR: Filing is a standard insider disposition notice; it fulfills Rule 144 disclosure requirements and raises no governance concerns from provided data.

The notice details the nature of acquisition (performance awards), payment date, broker, and proposed sale timing, meeting the form's informational requirements. The absence of sales in the prior three months and the signer027s representation regarding material undisclosed information are consistent with compliance expectations. Based solely on the information presented, there are no governance red flags or indications of irregular trading patterns.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	10000	489200	270665399	09/03/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	03/15/2025	Acquired as compensation -- Performance Awards	Issuer			10000	03/15/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What shares does the CNA Form 144 report cover?

The notice covers 10,000 shares of CNA common stock acquired as performance awards on 03/15/2025.

When is the proposed sale date and which broker is handling the transaction?

The proposed sale is dated 09/03/2025 and the broker is Goldman Sachs & Co. LLC.

What is the aggregate market value and how many shares are outstanding?

The aggregate market value reported is $489,200 and the issuer reports 270,665,399 shares outstanding.

Were any securities sold by the filer in the past three months?

The filing states "Nothing to Report" for securities sold during the past three months.

How were the acquired shares paid for according to the filing?

The acquisition and payment are listed as compensation, with payment dated 03/15/2025.